PRTODAY / NewswireToday Free press release distribution service network

Written by / Agency / Source: IM Publications LLP

Check Ads Availability|e-mail Article


Are you the owner of this article?, Turn it PREMIUM with your LOGO instead - and make it 3rd party Ads-Free! within the next hour!

Near Infrared Spectroscopy Helps in the Fight Against Counterfeit Drugs - Counterfeit medicines can be identified rapidly and precisely using a portable near infrared analyser and a technique developed by scientists at the School of Pharmacy, University of London
Near Infrared Spectroscopy Helps in the Fight Against Counterfeit Drugs

 

NewswireToday - /newswire/ - Chichester, West Sussex, United Kingdom, 2008/07/30 - Counterfeit medicines can be identified rapidly and precisely using a portable near infrared analyser and a technique developed by scientists at the School of Pharmacy, University of London.

   
 
Your Banner Ad Here instead - Showing along with ALL Articles covering Pharma/BioTech/Nutrition Announcements

Replace these Affiliate Programs at ANYTIME! Your banner here within the next hour. Learn How!


 

The counterfeiting of medicines has been known of since around 1990 and is a growing problem—in both developing and developed countries. Counterfeit medicines are estimated as more than 10% of the global medicines market and in some developing countries it is thought to be as high as 50%. One prediction is that global counterfeit drug sales will reach $75 billion by 2010.

Counterfeiting can apply to both branded and generic products, with counterfeit products including drugs with the correct ingredients or with the wrong ingredients; without active ingredients, with insufficient active ingredient or with fake packaging. The increased occurrence of counterfeit medicines has several serious consequences. These may include illness or death of patients, higher medical insurance and lost revenues to pharmaceutical manufacturers and governments. Children are particularly at risk. Diminished public confidence in both health care providers and the medicines supply chain could indirectly lead to increased illness (as a result of non-adherence) which would strain health care services. Damage to a brand’s credibility could tarnish a manufacturer’s reputation, not to forget the substantial loss of revenues.

The recent discovery of counterfeit medicines in the UK supply chain prompted Professor Moffat, Dr O’Neil and their colleagues at the Centre for Pharmaceutical Analysis, The School of Pharmacy, University of London, to develop a rapid, precise and portable analytical technique for in-field use. Working with samples provided by the Korean Food and Drugs Agency and a portable transmittance near infrared (NIR) spectrometer developed by NIR Technology Systems they have the answer to identifying counterfeits where they choose. This ability to replace laboratory analysis with the use of a portable instrument at the point of sampling is an attractive option for regulatory authorities. Furthermore, the NIR technique is rapid, precise, non-destructive and costs very little to operate.

Their findings have been published in the latest edition* of the Journal of Near Infrared Spectroscopy. “Near infrared spectroscopy is a scientific tool which has helped us understand the differences between genuine and counterfeit drugs, even those which look exactly the same to the naked eye,” Professor Moffat said.

As well as being able to identify counterfeit from genuine tablets, the chemical information provided by NIR spectroscopy helps identify the likely origin of the tablet. Thus law enforcement agencies obtain valuable information about the laboratories manufacturing counterfeit medicines.

The present paper was presented at the 13th International Conference on Near Infrared Spectroscopy in Umeå, Sweden. Professor Moffat, together with his students and collaborators, are also developing the technique of NIR spectroscopy for the quality assurance of medicines and to ensure that manufacturing methods are efficient and effective. “Our studies also have relevance to the formulation development of new medicines to make sure that patients get the right drug at the right amount at the right time”, said Professor Moffat.

*A.J. O'Neil, R.D. Jee, G. Lee, A. Charvill and A.C. Moffat, “Use of a portable NIR spectrometer for the authentication of tablets and the detection of counterfeit versions”, J. Near Infrared Spectrosc. 16(3), 327–333 (2008), doi: 10.1255/jnirs.796

About Journal of Near Infrared Spectroscopy
The Journal of Near Infrared Spectroscopy (JNIRS) is a peer review journal published by IM Publications. It publishes high-quality, original research papers on all aspects of near infrared (NIR) spectroscopy and technology. NIR spectroscopy is used widely in the food and agriculture, pharmaceutical and chemical industries, and is finding increasing applications in other areas including medicine and the environment.

For more information about the research, please contact:
Professor Moffat, Centre For Pharmaceutical Analysis, The School of Pharmacy, University of London, 29–39 Brunswick Square, London, WC1N 1AX, UK. P: 01954 782366, 07717-520667 (mobile), E: tony.moffat[.]pharmacy.ac.uk.

 
 
Your Banner Ad Here instead - Showing along with ALL Articles covering Pharma/BioTech/Nutrition Announcements

Replace these Affiliate Programs at ANYTIME! Your banner here within the next hour. Learn How!


 

Written by / Agency / Source: IM Publications LLP

 
 

Availability: All Regions (Including Int'l)

 

Traffic Booster: [/] Quick Newswire Today Visibility Checker

 

Distribution / Indexing: [+]

 
 
# # #
 

 
  Your Banner Ad showing on ALL
Pharma/BioTech/Nutrition articles,
CATCH Visitors via Your Competitors Announcements!


Near Infrared Spectroscopy Helps in the Fight Against Counterfeit Drugs

Company website links NOT available to basic submissions
It is OK to republish and/or LINK any newswire for any legitimate media purpose as long as you name Newswire Today and LINK as the source.
 
  Is this your article?
Activate ALL web links and social stream by Upgrading to Press Release PREMIUM Plan Now!

|
Publisher Contact: Ian Michael - IMPublications.co.uk 
+44(0)12 4381 1334 ian[.]impublications.co.uk
 
Newswire Today - PRZOOM / PRTODAY disclaims any content contained in this article. If you need/wish to contact the company who published the current release, you will need to contact them - NOT us. Issuers of articles are solely responsible for the accuracy of their content. Our complete disclaimer appears here.
IMPORTANT INFORMATION: Issuance, publication or distribution of this press release in certain jurisdictions could be subject to restrictions. The recipient of this press release is responsible for using this press release and the information herein in accordance with the applicable rules and regulations in the particular jurisdiction. This press release does not constitute an offer or an offering to acquire or subscribe for any IM Publications LLP securities in any jurisdiction including any other companies listed or named in this release.

Pharma/BioTech/Nutrition via RSSAdd NewswireToday - PRZOOM Headline News to FeedBurner
Find who RetweetFollow @NewswireTODAY



Are you the owner of this article?, Turn it PREMIUM with your LOGO instead - and make it 3rd party Ads-Free! within the next hour!


Read Latest Articles From IM Publications LLP / Company Profile


Read Pharma/BioTech/Nutrition Most Recent Related Newswires:

Greenphire Sponsors Second Annual Clinical Trial Agreements, Investigator Payments and Fair Market Value Meeting
Genentech’s Gazyva Helped People with Previously Untreated Follicular Lymphoma Live Significantly Longer
BD Announces Adoption of Windows 10 ‘Internet of Things’ for the Pyxis™ ES System
Greenphire Named to Deloitte 2016 Technology Fast 500™
Genentech Showcases New Clinical Data Across a Variety of Blood Diseases at American Society of Hematology 2016 Annual Meeting
BD Collaborates with JDRF to Focus on Extended Wear Innovations for Insulin Infusion Delivery
BD Launches First Syringe Designed for Use with Humulin® R U-500 Insulin
MDxHealth Announces Unique CPT Code Awarded for ConfirmMDx from the American Medical Association
BD MAX™ Vaginal Panel Receives FDA Market Authorization to Detect Most Common Causes of Vaginal Infections
Greenphire Receives EU-US Privacy Shield Certification
The 2016 Georges Mathé Prize Recognizes Research on the Immunological Determinants of the Response to Breast Cancer Treatment
MDxHealth Announces Agreement with HIFU CLINIC Prostate Cancer Center for Distribution of SelectMDx in Poland
First Patient in Malaysia Receives TheraSphere™ Radioembolisation Therapy
FDA Approves Genentech’s Lucentis® (Ranibizumab Injection) Prefilled Syringe
BTG and Mirada Medical Announce CE Mark Certification for Simplicit90Y Dosimetry Software in Europe

Boost Your Social Network
& Crowdfunding Campaigns


LIFETIME SOCIAL MEDIA WALL
NewswireToday Celebrates 10 Years in Business


PREMIUM Members


Visit  La Bella Bakery Artisan Bakery Arizona

Visit  Triggr & Bloom





 
  ©2016 Newswire Today — Limelon Advertising, Co.
Home | About | Advertise/Pricing | Contact | Investors | Privacy/TOS | Sitemap | FRANCAIS
newswire, PR free press releases distribution service magazines engine news alert newsroom press room breaking news public relations articles company news alerts newswiredistribution ezine bizentrepreneur biznewstoday digital business report market search pr firms agencies reports distri-bution today investor relation successful internet entrepreneurs newswire distribution prtoday.com freenewswiredistribution asianewstoday bizwiretoday USA pr UK today - NOT affiliated with PRNewswire as we declined their partnership offer in 2013
 
PRTODAY & NewswireTODAY are NOT affiliated with USA TODAY (usatoday.com)